Ablative therapies for locoregional therapy of pancreatic neoplastic lesions developed during the last decade to be utilized throughout surgical procedure at the moment are turning into additionally obtainable to be utilized underneath endoscopic ultrasound (EUS) steerage. The benefit of this strategy is obvious due to the shut proximity of the EUS transducer to the goal lesion, coupled with developments of particularly designed ablation gadgets, making the process minimally invasive, and probably sparing sufferers from the morbidity of this methodology when carried out surgically.
EUS-guided ablative methods which were utilized to pancreatic neoplastic cysts, pancreatic useful and non-functional neuroendocrine neoplasms and pancreatic ductal adenocarcinoma embody ethanol injection, radiofrequency ablation (RFA), a mix of bipolar RFA and cryoablation, laser remedy (LT) and photodynamic remedy (PDT). To this point, most of those procedures have been utilized to sufferers at excessive surgical threat or who refused surgical procedure. Nevertheless, extra research evaluating a few of these therapies additionally in chosen sufferers not at surgical threat have gotten obtainable.
These research will pave the street to use this therapeutic strategy to a extra in depth variety of sufferers, alone or in affiliation with different therapies, corresponding to immunomodulating medication. The current manuscript will critically assessment the obtainable proof within the subject of EUS-guided native ablative therapy of strong and cystic pancreatic neoplasms. Exosomes (EXOs) are small vesicles (30-200 nm) of endocytic origin, that are launched by many various cell sorts into the extracellular house. They might play a key position in facilitating cell-cell communication, underneath each physiological and pathological situations.
EXOs include a variety of RNA molecules and proteins. Their particular molecular signatures make them promising candidates in early analysis and prognosis of pancreatic ailments. EXOs might additionally present a brand new methodology to observe therapy response in sufferers affected by pancreatic most cancers and different ailments of the pancreas. Moreover they might assist to enhance present therapies through customized drugs approaches utilizing them as therapeutic automobiles themselves.
The exploration of quantitative intra-tumoral metabolic heterogeneity in dual-time 18 F-FDG PET/CT of pancreatic most cancers
In complete, 183 PC sufferers have been analyzed retrospectively on this analysis. The standard metabolic parameters have been all statistically totally different between the early and delayed scans apart from metabolic tumor quantity (MTV). Within the radiomics, there have been 59 textural options. Nineteen of 59 texture options have been statistically totally different between the early and delayed scans. Options that have been greater than 10% totally different throughout two scans have been noticed in a considerable proportion of sufferers. Weak correlations have been solely discovered between MTV, TLG (Complete lesion glycolysis), SUVpeak and the RI of some texture options in early or delayed scans.
There have been clearly fewer options with important distinction in resectable PC group than in unresectable PC group. Most options displaying the distinction in unresectable group whereas no important distinction in resectable group. Options have been extracted based mostly on spatial distribution of 18F-FDG uptake in picture. Firstly, the feel options and the traditional metabolic parameters of the delayed scan have been each in contrast with that of the early scan. Statistically totally different knowledge was outlined amongst them. Secondly, the research evaluated the correlations between retention index (RI) of the feel options and the traditional metabolic parameters.
Lastly, the variation of texture options in dual-time PET/CT of resectable PC sufferers and unresectable PC sufferers was calculated individually. The mRNA expression profiles and corresponding clinicopathological data of PAC sufferers have been downloaded from The Most cancers Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) database, respectively. To additional discover the impact of hypoxia on the prognosis of sufferers with PAC in addition to the tumor immune microenvironment, we established a hypoxia threat mannequin and divided it into high- and low-risk teams according to the hypoxia threat rating.
Lengthy non-coding RNA PART1 predicts a poor prognosis and promotes the malignant development of pancreatic most cancers by sponging miR-122
qRT-PCR was utilized to detect PART1 expression in 45 instances of pancreatic most cancers sufferers. The chi-square check was carried out to evaluate the affiliation between PART1 expression and clinicopathologic options, and Kaplan-Meier methodology was utilized to guage total survival. In vitro CCK-8, transwell invasion, and circulation cytometry assays have been utilized to detect the results of PART1 on cell proliferation, invasion, and apoptosis, respectively. Luciferase reporter and RNA immunoprecipitation assays have been used to determine the regulatory mechanism between PART1 and miR-122. PART1 expression was upregulated in pancreatic most cancers tissues and cell traces.
Excessive PART1 expression was carefully correlated with tumor dimension, T classification, medical stage, and vascular invasion, and predicted a poor total survival. PART1 knockdown considerably suppressed cell proliferation and invasion skills of pancreatic most cancers however promoted cell apoptosis. PART1 was discovered to function a molecular sponge of miR-122, and miR-122 inhibition partially reversed the inhibitory phenotypes of PART1 knockdown on pancreatic most cancers cells. The Editor requested the authors for an evidence to account for the looks of strikingly comparable knowledge of their paper independently, though the authors by no means responded inside an affordable time to substantiate that the paper must be retracted.
Cancer/Testis Antigen 5.1 (SSX1) Antibody |
abx302290-100g |
Abbexa |
100 µg |
EUR 362.5 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody |
abx302290-20g |
Abbexa |
20 µg |
EUR 162.5 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody |
abx302290-50g |
Abbexa |
50 µg |
EUR 250 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody |
abx145140-1096tests |
Abbexa |
10 × 96 tests |
Ask for price |
Cancer/Testis Antigen 5.1 (SSX1) Antibody |
abx145140-596tests |
Abbexa |
5 × 96 tests |
Ask for price |
Cancer/Testis Antigen 5.1 (SSX1) Antibody |
abx145140-96tests |
Abbexa |
96 tests |
EUR 337.5 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody |
abx238257-100g |
Abbexa |
100 µg |
EUR 350 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody |
abx323587-100g |
Abbexa |
100 µg |
EUR 250 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody |
abx323587-50g |
Abbexa |
50 µg |
EUR 187.5 |
Cancer/testis Antigen 2 (CTAG2) Antibody |
20-abx149592 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Cancer/testis Antigen 2 (CTAG2) Antibody |
abx027593-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Cancer/testis Antigen 2 (CTAG2) Antibody |
abx027593-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Cancer/testis Antigen 2 (CTAG2) Antibody |
abx027593-400l |
Abbexa |
400 µl |
EUR 518.75 |
Cancer/testis Antigen 2 (CTAG2) Antibody |
abx375499-96tests |
Abbexa |
96 tests |
EUR 337.5 |
Cancer/testis Antigen 2 (CTAG2) Antibody |
abx376324-96tests |
Abbexa |
96 tests |
EUR 225 |
Cancer/testis Antigen 2 (CTAG2) Antibody |
abx344921-100l |
Abbexa |
100 µl |
EUR 250 |
Cancer/testis Antigen 2 (CTAG2) Antibody |
abx344921-50l |
Abbexa |
50 µl |
EUR 187.5 |
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
abx331930-100ul |
Abbexa |
100 ul |
EUR 510 |
|
Cancer/Testis Antigen 1B (CTAG1B) Antibody |
20-abx171540 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
20-abx126874 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Cancer/Testis Antigen 1B (CTAG1B) Antibody |
20-abx128209 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
20-abx111352 |
Abbexa |
-
Ask for price
-
Ask for price
|
|
|
Cancer/Testis Antigen 1B (CTAG1B) Antibody |
20-abx135754 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ul
- 200 ul
- 20 ul
- 50 ul
|
|
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
abx027441-400ul |
Abbexa |
400 ul |
EUR 627.6 |
|
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
abx027441-80l |
Abbexa |
80 µl |
EUR 343.2 |
|
Cancer/Testis Antigen 1B (CTAG1B) Antibody |
abx128209-100l |
Abbexa |
100 µl |
EUR 275 |
Cancer/Testis Antigen 1B (CTAG1B) Antibody |
abx128209-1ml |
Abbexa |
1 ml |
EUR 750 |
Cancer/Testis Antigen 1B (CTAG1B) Antibody |
abx128209-200l |
Abbexa |
200 µl |
EUR 337.5 |
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
abx111352-100l |
Abbexa |
100 µl |
EUR 612.5 |
Cancer/Testis Antigen 1B (CTAG1B) Antibody |
abx135754-100tests |
Abbexa |
100 tests |
EUR 175 |
Cancer/Testis Antigen 1A (CTAG1A) Antibody |
abx027441-400l |
Abbexa |
400 µl |
EUR 518.75 |
Cancer/Testis Antigen 1B (CTAG1B) Antibody |
abx171540-1ml |
Abbexa |
1 ml |
EUR 787.5 |
Cancer/Testis Antigen 1 (CTAG1B) Antibody |
abx433062-100g |
Abbexa |
100 µg |
EUR 387.5 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody (HRP) |
20-abx316206 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Cancer/Testis Antigen 5.1 (SSX1) Antibody (HRP) |
abx316206-100g |
Abbexa |
100 µg |
EUR 362.5 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody (HRP) |
abx316206-20g |
Abbexa |
20 µg |
EUR 162.5 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody (HRP) |
abx316206-50g |
Abbexa |
50 µg |
EUR 250 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody (FITC) |
20-abx316207 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Cancer/Testis Antigen 5.1 (SSX1) Antibody (FITC) |
abx316207-100g |
Abbexa |
100 µg |
EUR 362.5 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody (FITC) |
abx316207-20g |
Abbexa |
20 µg |
EUR 162.5 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody (FITC) |
abx316207-50g |
Abbexa |
50 µg |
EUR 250 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody (Biotin) |
20-abx316208 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 1 mg
- 200 ug
- 20 ug
- 50 ug
|
|
Cancer/Testis Antigen 5.1 (SSX1) Antibody (Biotin) |
abx316208-100g |
Abbexa |
100 µg |
EUR 362.5 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody (Biotin) |
abx316208-20g |
Abbexa |
20 µg |
EUR 162.5 |
Cancer/Testis Antigen 5.1 (SSX1) Antibody (Biotin) |
abx316208-50g |
Abbexa |
50 µg |
EUR 250 |
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody |
CAU21749-100ul |
Biomatik Corporation |
100ul |
EUR 235.2 |
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody |
CAU21749-200ul |
Biomatik Corporation |
200ul |
EUR 294 |
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human) |
4-PAJ316Hu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B) |
Human Cancer/testis antigen 2 (CTAG2) |
1-CSB-YP006127HUa4 |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Cancer/testis antigen 2(CTAG2) expressed in Yeast |
Human Cancer/testis antigen 2 (CTAG2) |
1-CSB-EP006127HU |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Cancer/testis antigen 2(CTAG2) expressed in E.coli |
Human Cancer/testis antigen 1 (CTAG1A) |
1-CSB-YP006125HU |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Cancer/testis antigen 1(CTAG1A) expressed in Yeast |
Human Cancer/testis antigen 1 (CTAG1A) |
1-CSB-EP006125HU |
Cusabio |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ug
- 10ug
- 1MG
- 200ug
- 500ug
- 50ug
|
|
Description: Recombinant Human Cancer/testis antigen 1(CTAG1A) expressed in E.coli |
Cancer/Testis Antigen 5.1 (SSX1) Protein |
abx262587-10mg |
Abbexa |
10 mg |
EUR 325 |
Cancer/Testis Antigen 5.1 (SSX1) Protein |
abx262587-25mg |
Abbexa |
25 mg |
EUR 6575 |
Cancer/Testis Antigen 5.1 (SSX1) Protein |
abx262587-5mg |
Abbexa |
5 mg |
EUR 225 |
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), PE |
4-PAJ316Hu01-PE |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with PE. |
Rat Cancer/testis antigen 1 ELISA kit |
E01A15093 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), APC |
4-PAJ316Hu01-APC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with APC. |
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), Cy3 |
4-PAJ316Hu01-Cy3 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with Cy3. |
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), HRP |
4-PAJ316Hu01-HRP |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with HRP. |
Recombinant Cancer/Testis Antigen 1B (CTAG1B) |
RPJ316Hu01 |
Cloud-Clone |
10ug |
EUR 174 |
Recombinant Cancer/Testis Antigen 1B (CTAG1B) |
4-RPJ316Hu01 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10ug
- 1 mg
- 200 ug
- 500 ug
- 50ug
- 5 mg
|
|
Description: Recombinant Human Cancer/Testis Antigen 1B expressed in: E.coli |
Recombinant Cancer/Testis Antigen 1B (CTAG1B) |
RPJ316Hu02 |
Cloud-Clone |
10ug |
EUR 176 |
Recombinant Cancer/Testis Antigen 1B (CTAG1B) |
RPJ316Hu03 |
Cloud-Clone |
10ug |
EUR 177 |
Goat Cancer/testis antigen 1 ELISA kit |
E01A49996 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), FITC |
4-PAJ316Hu01-FITC |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with FITC. |
Sheep Cancer/testis antigen 1 ELISA kit |
E01A102290 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Human Cancer/testis antigen 1 ELISA kit |
E01A6345 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Mouse Cancer/testis antigen 1 ELISA kit |
E01A23840 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Canine Cancer/testis antigen 1 ELISA kit |
E01A67426 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Rabbit Cancer/testis antigen 1 ELISA kit |
E01A32562 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Monkey Cancer/testis antigen 1 ELISA kit |
E01A76143 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Bovine Cancer/testis antigen 1 ELISA kit |
E01A84863 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Porcine Cancer/testis antigen 1 ELISA kit |
E01A58714 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Chicken Cancer/testis antigen 1 ELISA kit |
E01A93576 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Human Cancer/Testis Antigen 1B (CTAG1B) Protein |
20-abx166945 |
Abbexa |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Cancer/Testis Antigen 1B (CTAG1B) Protein |
abx166945-100g |
Abbexa |
100 µg |
EUR 575 |
Human Cancer/Testis Antigen 1B (CTAG1B) Protein |
abx166945-10g |
Abbexa |
10 µg |
EUR 225 |
Human Cancer/Testis Antigen 1B (CTAG1B) Protein |
abx166945-50g |
Abbexa |
50 µg |
EUR 400 |
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), Biotinylated |
4-PAJ316Hu01-Biotin |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with Biotin. |
Cancer/Testis Antigen 1B (CTAG1B) Polyclonal Antibody (Human), APC-Cy7 |
4-PAJ316Hu01-APC-Cy7 |
Cloud-Clone |
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
-
Ask for price
|
- 100ul
- 10ml
- 1ml
- 200ul
- 20ul
|
|
Description: A Rabbit polyclonal antibody against Human Cancer/Testis Antigen 1B (CTAG1B). This antibody is labeled with APC-Cy7. |
Rat Cancer/testis antigen 2(CTAG2) ELISA kit |
E02C2141-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Cancer/testis antigen 2(CTAG2) ELISA kit |
E02C2141-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Cancer/testis antigen 2(CTAG2) ELISA kit |
E02C2141-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Cancer/testis antigen 2(CTAG2) ELISA kit |
E08C2141-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Cancer/testis antigen 2(CTAG2) ELISA kit |
E08C2141-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Cancer/testis antigen 2(CTAG2) ELISA kit |
E08C2141-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Canine Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Cancer/testis antigen 2(CTAG2) ELISA kit |
E07C2141-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Cancer/testis antigen 2(CTAG2) ELISA kit |
E07C2141-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Cancer/testis antigen 2(CTAG2) ELISA kit |
E07C2141-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Cancer/testis antigen 2(CTAG2) ELISA kit |
E01A12375 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Recombinant Human Cancer/testis antigen 2 (CTAG2) |
CSB-YP006127HUa4 |
Cusabio |
5595 mg |
Ask for price |
Recombinant Human Cancer/testis antigen 2 (CTAG2) |
CSB-EP006127HU |
Cusabio |
915 mg |
Ask for price |
Recombinant Human Cancer/testis antigen 2(CTAG2) |
AP70203 |
SAB |
1mg |
EUR 1978 |
|
Recombinant Human Cancer/testis antigen 2(CTAG2) |
AP77850 |
SAB |
each |
Ask for price |
|
Goat Cancer/testis antigen 2(CTAG2) ELISA kit |
E01A47287 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Guinea Pig Cancer/testis antigen 1 ELISA kit |
E01A41276 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Rat Cancer/testis antigen 1(CTAG1A) ELISA kit |
E02C2140-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Rat Cancer/testis antigen 1(CTAG1A) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Cancer/testis antigen 1(CTAG1A) ELISA kit |
E02C2140-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Rat Cancer/testis antigen 1(CTAG1A) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Rat Cancer/testis antigen 1(CTAG1A) ELISA kit |
E02C2140-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Rat Cancer/testis antigen 1(CTAG1A) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Cancer/testis antigen 2(CTAG2) ELISA kit |
E06C2141-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Goat Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Cancer/testis antigen 2(CTAG2) ELISA kit |
E06C2141-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Goat Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Goat Cancer/testis antigen 2(CTAG2) ELISA kit |
E06C2141-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Goat Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Cancer/testis antigen 1(CTAG1A) ELISA kit |
E08C2140-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Canine Cancer/testis antigen 1(CTAG1A) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Cancer/testis antigen 1(CTAG1A) ELISA kit |
E08C2140-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Canine Cancer/testis antigen 1(CTAG1A) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Dog Cancer/testis antigen 1(CTAG1A) ELISA kit |
E08C2140-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Canine Cancer/testis antigen 1(CTAG1A) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Cancer/testis antigen 1(CTAG1A) ELISA kit |
E07C2140-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Cancer/testis antigen 1(CTAG1A) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Cancer/testis antigen 1(CTAG1A) ELISA kit |
E07C2140-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Cancer/testis antigen 1(CTAG1A) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Pig Cancer/testis antigen 1(CTAG1A) ELISA kit |
E07C2140-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Porcine Cancer/testis antigen 1(CTAG1A) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Cancer/testis antigen 75, CT75 ELISA KIT |
ELI-32971h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Human Cancer/testis antigen 62, CT62 ELISA KIT |
ELI-47629h |
Lifescience Market |
96 Tests |
EUR 988.8 |
Rat Cancer/testis antigen 1(CTAG1A) ELISA kit |
E01A12374 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Human Cancer/Testis Antigen 5.1 (SSX1) ELISA Kit |
abx383476-96tests |
Abbexa |
96 tests |
EUR 1093.2 |
|
ELISA Kit for Cancer/Testis Antigen 1B (CTAG1B) |
SEJ316Hu |
Cloud-Clone |
96Т |
EUR 700 |
|
Human Cancer/Testis Antigen 5.1 (SSX1) ELISA Kit |
abx383476-1096tests |
Abbexa |
10 × 96 tests |
Ask for price |
Human Cancer/Testis Antigen 5.1 (SSX1) ELISA Kit |
abx383476-596tests |
Abbexa |
5 × 96 tests |
Ask for price |
Human Cancer/testis antigen 55 (CT55) ELISA Kit |
abx509025-1096tests |
Abbexa |
10 × 96 tests |
Ask for price |
Human Cancer/testis antigen 55 (CT55) ELISA Kit |
abx509025-596tests |
Abbexa |
5 × 96 tests |
Ask for price |
Human Cancer/testis antigen 55 (CT55) ELISA Kit |
abx509025-96tests |
Abbexa |
96 tests |
EUR 687.5 |
Human Cancer/testis antigen 62 (CT62) ELISA Kit |
abx509026-96tests |
Abbexa |
96 tests |
EUR 687.5 |
Human CT62 / Cancer/testis antigen 62 ELISA Kit |
E15694h |
EIAab |
96T |
EUR 736 |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
CSB-YP006125HU |
Cusabio |
5594 mg |
Ask for price |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
CSB-EP006125HU |
Cusabio |
914 mg |
Ask for price |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
CSB-MP006125HU |
Cusabio |
4904 mg |
Ask for price |
Recombinant Human Cancer/testis antigen 1(CTAG1A) |
AP72513 |
SAB |
each |
Ask for price |
|
Recombinant Human Cancer/testis antigen 1(CTAG1A) |
AP77401 |
SAB |
1mg |
EUR 1978 |
|
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
RPC27218-100ug |
Biomatik Corporation |
100ug |
EUR 1931.2 |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
RPC21152-100ug |
Biomatik Corporation |
100ug |
EUR 460.9 |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
RPC21152-20ug |
Biomatik Corporation |
20ug |
EUR 258.7 |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
RPC20225-100ug |
Biomatik Corporation |
100ug |
EUR 573.1 |
Recombinant Human Cancer/testis antigen 1 (CTAG1A) |
RPC20225-20ug |
Biomatik Corporation |
20ug |
EUR 288.8 |
Human Cancer/Testis Antigen 2 (CTAG2)ELISA Kit |
201-12-2865 |
SunredBio |
96 tests |
EUR 528 |
|
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
Human Cancer/testis antigen 2(CTAG2) ELISA kit |
E01A3614 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Goat Cancer/testis antigen 1(CTAG1A) ELISA kit |
E01A47286 |
BlueGene |
96T |
EUR 700 |
Description: ELISA |
Human Cancer/testis antigen 2(CTAG2) ELISA kit |
E01C2141-192T |
BlueGene |
192 tests |
EUR 1524 |
|
Description: A competitive ELISA for quantitative measurement of Human Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Cancer/testis antigen 2(CTAG2) ELISA kit |
E01C2141-48 |
BlueGene |
1 plate of 48 wells |
EUR 624 |
|
Description: A competitive ELISA for quantitative measurement of Human Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Human Cancer/testis antigen 2(CTAG2) ELISA kit |
E01C2141-96 |
BlueGene |
1 plate of 96 wells |
EUR 822 |
|
Description: A competitive ELISA for quantitative measurement of Human Cancer/testis antigen 2(CTAG2) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
The Editor has subsequently made the manager determination to retract this paper. The Editor apologizes to the readership for any inconvenience prompted. Thirty sufferers who underwent TP have been eligible for the research. Bowel motion frequency elevated over time, and the RBW and TSFT have been lowest by 1 12 months. The worldwide well being standing rating confirmed no important distinction over time.